PAVmed's Veris Health Partners with Ohio State University for Cancer Care Advancement

PAVmed Inc., a pioneering medical technology company, recently announced an exciting partnership between its subsidiary, Veris Health, and The Ohio State University Comprehensive Cancer Center (OSUCCC – James). This strategic agreement marks a significant step forward for both organizations in their shared mission to enhance cancer care through advanced technological solutions.

A New Era in Cancer Care

The partnership stems from the successful pilot program that Veris Health conducted at OSUCCC – James. This program enrolled a wide array of patients across various cancer care service lines, utilizing the Veris Cancer Care Platform™. The results were promising, showcasing the platform's potential to improve patient monitoring and treatment outcomes. Inspired by these findings, both parties are eager to transition into a long-term, multi-project collaboration.

Dr. Brian deGuzman, Chief Operating Officer of Veris Health, expressed enthusiasm about the partnership's potential: "We are thrilled to advance our strategic partnership with OSUCCC – James, one of the largest and most prestigious academic cancer centers in the nation, following the successful completion of a pilot program demonstrating the strong clinical utility of our platform."

Expanding the Cancer Care Ecosystem

Under the terms of the new agreement, Veris Health and OSUCCC – James plan to implement and further develop the Veris Cancer Care Platform, alongside its implantable physiological monitor features. This includes full electronic health record (EHR) integration and the initiation of a large clinical registry for patients enrolled on the platform. Soon, they will also launch a significant clinical trial focusing on patients receiving the implantable monitor, pending FDA clearance anticipated next year.

This collaboration will enhance the capabilities of both entities with the development of clinical cancer care pathways, software enhancements for the platform, and identification of best practices for the clinical use of the physiological monitor.

Combining Innovation with Patient Care

The Veris Cancer Care Platform is designed to revolutionize cancer treatment by allowing remote collection of physiological data and symptom reporting from patients. This innovative platform not only supports telehealth capabilities but also integrates with electronic health records—promoting seamless communication between healthcare providers and patients.

Patients enrolled will receive a VerisBox™, a collection of connected healthcare devices that communicate physiological information to a cloud-based clinician portal through cellular technology. The platform empowers patients with a dedicated smartphone app, enabling them to report symptoms and general health metrics efficiently. Moreover, the app allows patients to include family members and caregivers in their care journey, providing a support system that's critical during challenging times.

Future of Cancer Treatment

The commitment from OSUCCC – James to enhancing personalized cancer care aligns perfectly with Veris Health's mission. Dr. David Cohn, Chief Operating Officer and Chair of Gynecologic Oncology at The James Cancer Hospital, echoed this sentiment: "After a successful pilot program, we are excited to be entering into a long-term strategic partnership with Veris Health to expand access to the Veris Cancer Care Platform and enhance the care of our patients." This partnership signifies an evolution in cancer treatment, emphasizing innovative technology's role in providing personalized care.

As research and application of the platform progresses, the implications for patients receiving cancer treatment could be profound. By adopting this cutting-edge approach, Veris Health, in collaboration with OSUCCC – James, aims to detect complications at an early stage, reduce unplanned hospitalizations, and provide valuable longitudinal data to inform patient management decisions.

Looking Ahead

As the partnership unfolds, Veris Health and OSUCCC – James are set to lead the charge in integrating technology with patient care. This collaboration highlights a growing trend in the healthcare sector toward personalized, data-driven strategies that empower both patients and providers. Those interested in learning more about Veris Health and its innovative cancer care platform can visit verishealth.com.

In summary, the strategic partnership between PAVmed's Veris Health and Ohio State University Comprehensive Cancer Center embodies a significant step toward improving cancer care and patient outcomes, promising a future where technology plays an essential role in healthcare delivery.